Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
114.10
+0.16
+(0.14%)
At close: February 21 at 4:19:45 PM GMT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Flemming Ornskov M.B.A., M.P.H. | CEO & Director | -- | -- | 1958 |
| Mr. Thomas J. W. Dittrich | Chief Financial Officer | -- | -- | 1964 |
| Mr. Adrian Murphy | Head of Global Operations | -- | -- | 1970 |
| Mr. Emil Ivanov | Head of Strategy, Investor Relations & ESG | -- | -- | -- |
| Mr. Christian Marcoux | Chief Communications Officer | -- | -- | -- |
| Ms. Allison Pinkham | Chief Human Resources Officer | -- | -- | 1975 |
Galderma Group AG
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 6,545
Description
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Corporate Governance
Galderma Group AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 6, 2025 at 6:00 AM UTC
Galderma Group AG Earnings Date
Recent Events
Recent Events Information Not Available